The Tough Tech problem we are solving
The ability to precisely regulate gene expression is the holy grail of modern medicine today. While RNA-based approaches hold great promise, existing technologies face major limitations in precision, efficacy, and durability. As a result, many diseases remain untreatable, and the full potential of RNA medicine has yet to be realized.
About our solution
Collage Bio is pioneering a novel class of RNA therapeutics that push beyond current limitations. With an AI-enhanced polynucleotide engineering framework, we create highly stable, specific, and programmable medicines to address unmet therapeutic needs. Our approach combines the durability of gene editing with the ability to modulate disease mechanisms safely and reversibly, enabling scalable and modular therapies for a wide range of diseases.